DC Investments Management’s Gilead Sciences GILD Stock Holding History

DC Investments Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,281	Closed	-$541K	–	55
2020 Q4	$541K	Sell	9,281 -3,028	-25%	-$183K	1.35%	22
2020 Q3	$778K	Buy	12,309 +7,721	+168%	+$535K	0.85%	31
2020 Q2	$353K	Sell	4,588 -67,862	-94%	-$5.2M	0.13%	125
2020 Q1	$5.42M	Buy	+72,450	New	+$5.01M	4.39%	2
2019 Q4	–	Sell	-5,046	Closed	-$320K	–	271
2019 Q3	$320K	Buy	5,046 +1,624	+47%	+$106K	0.19%	243
2019 Q2	$231K	Buy	+3,422	New	+$225K	0.13%	289

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

DC Investments Management's GILD Position: Q1 2021 in Review

DC Investments Management sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 9,281 shares — an estimated $541K sold.

DC Investments Management first reported a position in GILD in Q2 2019 and held it in 6 quarters. The position peaked at $5.42M in Q1 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

DC Investments Management reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
DC Investments Management sold 9,281 Gilead Sciences shares in Q1 2021, an estimated $541K.
DC Investments Management first reported a position in Gilead Sciences in Q2 2019 and held it in 6 quarters.
DC Investments Management's Gilead Sciences position peaked at $5.42M in Q1 2020.
1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on DC Investments Management's 13F filing for Q1 2021, filed 14 May 2021.